Return to homepagePandemic Pact

A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA133345

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $2,129,646.42

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

In response to the COVID-19 pandemic greater than200 vaccine candidates are in active development and greater than20 in clinical trials. While we hope that these 'first generation' vaccines will be safe and effective, there are sure to be challenges in deploying these vaccines to all parts of the globe, including Australia, in a timely manner. Accordingly, we have developed two vaccine candidates with significant novelty, tempered by realistic deployment imperatives, to be deployed in this global emergency.